Show simple item record

dc.contributor.authorBurnett, Melissah
dc.contributor.authorMannix, Trudi Gaye
dc.date.accessioned2012-06-21T02:57:18Z
dc.date.available2012-06-21T02:57:18Z
dc.date.issued2012
dc.identifier.citationBurnett, M. and Mannix, T.G., 2012. Cochrane Review summary: High flow nasal cannula for respiratory support in preterm infants. Neonatal, Paediatric and Child Health Nursing, 15(1), 28-29.en
dc.identifier.issn1441-6638
dc.identifier.urihttp://hdl.handle.net/2328/26120
dc.description.abstractIn the preterm infant requiring respiratory support for apnoea, respiratory distress syndrome (RDS) or chronic lung disease (CLD), a variety of non-invasive ventilation options are available. Nasal continuous positive airway pressure (CPAP) is commonly used as an alternative to endotracheal intubation and more recently, high flow nasal cannula (HFNC) is being used to deliver positive end-expiratory pressure (PEEP), oxygen, blended oxygen and air. Both methods however may have adverse effects despite being moderately easy to apply and manage. The most significant risks related to nasal CPAP are nasal trauma and distortion of the nares, and for HFNC, mucosal irritation, obstruction, nosocomial infection and possible lung injury from PEEP which is not measured and inconsistent. The aim of this Cochrane Review was to compare the safety and efficacy of HFNC with other forms of non-invasive respiratory support in preterm infants.en
dc.language.isoen
dc.publisherNeonatal Paediatric and Child Health Nursingen
dc.subjectHealth
dc.subjectChildren
dc.subjectRespiratory function
dc.subjectNeonatal care
dc.titleCochrane Review summary: High flow nasal cannula for respiratory support in preterm infantsen
dc.typeArticleen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record